A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
Public ClinicalTrials.gov record NCT04102020. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Phase 3 Study of Venetoclax and Azacitidine as Maintenance Therapy for Patients With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
Study identification
- NCT ID
- NCT04102020
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 112 participants
Conditions and interventions
Conditions
Interventions
- Azacitidine Drug
- Venetoclax Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 25, 2020
- Primary completion
- Sep 28, 2022
- Completion
- Feb 19, 2026
- Last update posted
- Apr 7, 2026
2020 – 2026
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mitchell Cancer Institute /ID# 216443 | Mobile | Alabama | 36604 | — |
| Compassionate Cancer Care Research Group - Fountain Valley /ID# 216156 | Fountain Valley | California | 92708-7501 | — |
| University of California, Los Angeles /ID# 219149 | Los Angeles | California | 90095 | — |
| Colorado Blood Cancer Institute /ID# 214280 | Denver | Colorado | 80218 | — |
| St. Alphonsus Regional Medical /ID# 216424 | Boise | Idaho | 83706 | — |
| Duplicate_Rush University Medical Center /ID# 218815 | Chicago | Illinois | 60612 | — |
| University of Kentucky Markey Cancer Center /ID# 215048 | Lexington | Kentucky | 40536-7001 | — |
| Duplicate_Norton Cancer Institute /ID# 216401 | Louisville | Kentucky | 40202-3700 | — |
| Tulane Medical Center - New Orleans /ID# 218166 | New Orleans | Louisiana | 70112-2600 | — |
| Duplicate_Ochsner Clinic Foundation-New Orleans /ID# 214583 | New Orleans | Louisiana | 70121 | — |
| Tufts Medical Center /ID# 216110 | Boston | Massachusetts | 02111-1552 | — |
| Massachusetts General Hospital /ID# 217307 | Boston | Massachusetts | 02114 | — |
| Duplicate_UMass Chan Medical School /ID# 218163 | Worcester | Massachusetts | 01655 | — |
| Oncology Hematology Associates (OHA) - Springfield /ID# 216351 | Springfield | Missouri | 65807-5287 | — |
| Saint Louis University Cancer Center /ID# 218164 | St Louis | Missouri | 63110-2539 | — |
| The John Theurer Cancer /ID# 215191 | Hackensack | New Jersey | 07601 | — |
| Rutgers Cancer Institute of New Jersey /ID# 239708 | New Brunswick | New Jersey | 08901 | — |
| Weill Cornell Medical College /ID# 214847 | New York | New York | 10065 | — |
| Providence Portland Medical Ct /ID# 216231 | Portland | Oregon | 97213-2933 | — |
| Fox Chase Cancer Center /ID# 239372 | Philadelphia | Pennsylvania | 19111 | — |
| UPMC Hillman Cancer Ctr /ID# 214051 | Pittsburgh | Pennsylvania | 15232 | — |
| Duplicate_Prisma Health Cancer Institute-Faris Road /ID# 216066 | Greenville | South Carolina | 29605-4255 | — |
| St Francis Cancer Center /ID# 216115 | Greenville | South Carolina | 29607-5253 | — |
| Gibbs Cancer Center & Research /ID# 216192 | Spartanburg | South Carolina | 29303-3040 | — |
| Tennessee Oncology-Nashville Centennial /ID# 218757 | Nashville | Tennessee | 37203-1632 | — |
| Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 214584 | Dallas | Texas | 75246-2003 | — |
| University of Texas MD Anderson Cancer Center /ID# 225201 | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 129 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04102020, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04102020 live on ClinicalTrials.gov.